2.0
6. Apr. 2010
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Well respected in industry Strong pipeline (esp. Oncology) Fiscally well positioned vs peers / best big Pharma company in terms of diversification Talented employees
Kontras
Too much "red tape" - also used to be a company where reward & recognition towards employee was key focus, now less so...